Straits Times Index
3,324.28 -2.00 (-0.06%) Nikkei
39,657.36 +484.21 (+1.24%) Hang Seng
18,124.37 +51.47 (+0.28%) FTSE 100
8,247.79 -33.76 (-0.41%) Bitcoin USD
61,652.68 +333.63 (+0.54%) CMC Crypto 200
1,280.48 +31.35 (+2.51%)
Delcath Systems Inc (DV3R.F)
| Previous close | 7.45 |
| Open | 7.55 |
| Bid | 7.65 x N/A |
| Ask | 7.90 x N/A |
| Day's range | 7.55 - 7.55 |
| 52-week range | 2.18 - 7.55 |
| Volume | |
| Avg. volume | 34 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors
NEW YORK, May 28, 2024--Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, is pleased to announce the appointment of Dr. Bridget Martell to the Company’s Board of Directors effective May 23, 2024.
- PR Newswire
Delcath Systems Reports First Quarter 2024 Results and Business Highlights
Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported financial results and business highlights for the first quarter ended March 31, 2024.
- PR Newswire
Delcath Systems to Host First Quarter 2024 Earnings Call
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on May 14, 2024, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2024.
